XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the top 10 rebounding Mid Cap stocks. These companies are interesting turnaround stories. One Chinese company (MPEL) is on the list. Pharmasset, Inc. (NASDAQ:VRUS) is the 1st best rebounding stock in this segment of the market. It has risen 416% from its 52-week low. It is now trading at 93% of its 52-week high. CVR Energy, Inc. (NYSE:CVI) is the 2nd best rebounding stock in this segment of the market. It has risen 253% from its 52-week low. It is now trading at 91% of its 52-week high. Valhi, Inc. (NYSE:VHI) is the 3rd best rebounding stock in this segment of the market. It has risen 243% from its 52-week low. It is now trading at 92% of its 52-week high. Molycorp, Inc. (NYSE:MCP) is the 4th best rebounding stock in this segment of the market. It has risen 209% from its 52-week low. It is now trading at 69% of its 52-week high. Apco Oil & Gas International Inc. (NASDAQ:APAGF) is the 5th best rebounding stock in this segment of the market. It has risen 209% from its 52-week low. It is now trading at 80% of its 52-week high. Lululemon Athletica inc. (NASDAQ:LULU) is the 6th best rebounding stock in this segment of the market. It has risen 207% from its 52-week low. It is now trading at 82% of its 52-week high. Accretive Health, Inc. (NYSE:AH) is the 7th best rebounding stock in this segment of the market. It has risen 201% from its 52-week low. It is now trading at 76% of its 52-week high. Golar LNG Limited (USA) (NASDAQ:GLNG) is the 8th best rebounding stock in this segment of the market. It has risen 198% from its 52-week low. It is now trading at 80% of its 52-week high. Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) is the 9th best rebounding stock in this segment of the market. It has risen 188% from its 52-week low. It is now trading at 76% of its 52-week high. Cabot Oil & Gas Corporation (NYSE:COG) is the 10th best rebounding stock in this segment of the market. It has risen 179% from its 52-week low. It is now trading at 94% of its 52-week high.
No comments:
Post a Comment